We may earn a commission when readers sign up through partner links. Rankings reflect our published methodology, not advertiser fees.
Ranked #7

Sequence (WeightWatchers Clinic)

WeightWatchers Clinic — insurance-pathway brand-name GLP-1 with WW behavioral framework

74 / 100
★★★★☆
4.0

What Sequence (WeightWatchers Clinic) Does Right

Sequence is the GLP-1 telehealth arm of WeightWatchers, branded as WW Clinic in some markets. The acquisition gives Sequence access to the WW behavioral-coaching framework, weigh-in infrastructure, and member community — assets no other GLP-1 telehealth competitor has. For patients who already trust the WW behavioral methodology and want it paired with GLP-1 prescribing, Sequence is a coherent integrated offering.

The clinical workflow includes physician evaluation, brand-name GLP-1 prescribing with insurance navigation, and integration with WW's app for habit-tracking and coaching. The $99/month program fee includes WW membership, which is a structural advantage if the patient was paying for WW separately.

Where Sequence (WeightWatchers Clinic) Could Improve

Sequence focuses entirely on brand-name FDA-approved GLP-1s and does not offer a compounded pathway — patients without insurance coverage face the full brand-name list price on top of the program fee. The 5–10 business day onboarding window is slow vs consumer-app competitors. The WW integration is valuable for some patients and feels like overhead to others; patients who don't want behavioral coaching are paying for content they won't use. Recent WeightWatchers parent-company financial difficulties create some uncertainty about long-term Sequence operating commitment.

Provider Snapshot

Medications
Wegovy, Zepbound, Ozempic, Mounjaro
Starting price
$99/mo (program fee)
Pricing model
Program fee + medication
Clinician type
MD / DO / NP
Labs
Add-on
3rd-party testing
N/A (brand-name only)
State availability
All 50 states
Certifications
LegitScript, BBB
Time to first Rx
5–10 business days

Pros

  • WW behavioral framework integration
  • Brand-name GLP-1 prescribing
  • All 50 states
  • Insurance pathway for covered plans
  • WW community access included
  • Established consumer brand

Cons

  • No compounded pathway
  • Program fee on top of medication
  • 5–10 business day onboarding
  • Parent-company financial uncertainty
  • Less clinical specialization than Form
17/25Price Transparency
19/25Clinical Protocol
15/20Prescriber Access
16/20Patient Outcomes
7/10Op. Transparency
Bottom line

Sequence is the right pick for committed WW members who want their existing behavioral framework integrated with GLP-1 prescribing. Patients without an existing WW investment will find better economics elsewhere.

Compare to NexLife → All providers →

How Sequence (WeightWatchers Clinic) compares

Compare Sequence (WeightWatchers Clinic) side-by-side

Frequently asked questions

How much does Sequence (WeightWatchers Clinic) cost?

Sequence (WeightWatchers Clinic) pricing ranges from $99/mo + medication. Starting price is $99/month. Pricing details and any titration upcharges are described above in the pricing section.

Is Sequence (WeightWatchers Clinic) legitimate?

Sequence (WeightWatchers Clinic) is an established telehealth program. Trusted-brand option. Insurance-friendly. Always verify a provider's pharmacy partnerships, prescribing physician credentials, and state availability before signing up.

Does Sequence (WeightWatchers Clinic) accept insurance?

Most direct-to-consumer compounded GLP-1 programs do not accept insurance for the medication itself. If insurance coverage matters to you, see our insurance pathway providers (Mochi Health, Ro, Form Health) and our insurance hub.

What medications does Sequence (WeightWatchers Clinic) prescribe?

Sequence (WeightWatchers Clinic) prescribes: Wegovy, Zepbound, Saxenda.

In what states is Sequence (WeightWatchers Clinic) available?

Sequence (WeightWatchers Clinic) is available in All 50 states.

Who can use Sequence (WeightWatchers Clinic)?

Eligibility is determined by an intake questionnaire and clinical review. Generally, FDA-approved weight-loss criteria are BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (Type 2 diabetes, hypertension, dyslipidemia, sleep apnea). Off-label compounded prescribing is at the discretion of the prescribing clinician.

Editorial note. By GLP Agonists Editorial · Last updated May 2026. This review is editorially independent. See our methodology and editorial disclosure. Not medical advice — always consult a licensed clinician.